| Welcure Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524661 |
NSE Symbol : - |
P/E(TTM) : 110.38 |
|
ISIN Demat : INE331C01017 |
Div & Yield% : - |
EPS(TTM) : 0.13 |
|
Book Value(₹) : 9.06 |
Market Cap(₹Cr) : 161.45 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 24.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 24.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.06 | 0.04 | 0.00 | 0.00 |
| Total Income | 24.55 | 0.00 | 0.06 | 0.04 | 0.00 | 0.00 |
| Total Expenditure | 22.71 | 0.34 | 0.05 | 0.06 | 0.09 | 0.03 |
| PBIDT | 1.84 | -0.34 | 0.00 | -0.02 | -0.09 | -0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 1.84 | -0.34 | 0.00 | -0.02 | -0.09 | -0.03 |
| Depreciation | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.84 | -0.35 | -0.02 | -0.03 | -0.10 | -0.03 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.84 | -0.35 | -0.02 | -0.03 | -0.10 | -0.03 |
| EPS (Unit Curr.) | 0.16 | -0.26 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS (Adj) (Unit Curr.) | 0.16 | -0.26 | -0.01 | -0.02 | -0.01 | -0.02 |
| Calculated EPS (Unit Curr.) | 0.16 | -0.26 | -0.01 | -0.02 | -0.07 | -0.02 |
| Calculated EPS (Adj) (Unit Curr.) | 0.16 | -0.26 | -0.01 | -0.02 | -0.07 | -0.02 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.65 | -1.03 | -0.05 | -0.08 | -0.28 | -0.10 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.65 | -1.03 | -0.05 | -0.08 | -0.28 | -0.10 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 112.44 | 13.44 | 13.44 | 13.44 | 13.44 | 13.44 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 7.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 7.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PATM(%) | 7.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |